Summary of Research: Ten-Year Safety and Clinical Benefit from Open-Label Etanercept Treatment in Children and Young Adults with Juvenile Idiopathic Arthritis

The trial was designed jointly by PRINTO investigators (NR, AM) and the sponsor. Data were collected by the PRINTO investigators. The sponsor was involved in the overall management of the trial, data collection, and data analysis. All authors reviewed and approved the final document.

留言 (0)

沒有登入
gif